Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Accounts Payables (2018 - 2025)

Historic Accounts Payables for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $12.2 million.

  • TransMedics' Accounts Payables fell 740.06% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year decrease of 740.06%. This contributed to the annual value of $10.3 million for FY2024, which is 1906.9% down from last year.
  • TransMedics' Accounts Payables amounted to $12.2 million in Q3 2025, which was down 740.06% from $9.5 million recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Accounts Payables peaked at $13.1 million during Q3 2024, and registered a low of $1.3 million during Q1 2021.
  • Over the past 5 years, TransMedics' median Accounts Payables value was $7.0 million (recorded in 2023), while the average stood at $7.5 million.
  • Data for TransMedics' Accounts Payables shows a peak YoY increase of 45149.25% (in 2021) and a maximum YoY decrease of 7347.74% (in 2021) over the last 5 years.
  • TransMedics' Accounts Payables (Quarter) stood at $6.7 million in 2021, then plummeted by 49.77% to $3.3 million in 2022, then soared by 280.63% to $12.7 million in 2023, then decreased by 19.07% to $10.3 million in 2024, then rose by 18.17% to $12.2 million in 2025.
  • Its Accounts Payables stands at $12.2 million for Q3 2025, versus $9.5 million for Q2 2025 and $10.6 million for Q1 2025.